Adipokines and central control in adenosine A1 receptor dependent glucose metabolism

Faulhaber-Walter, Robert
April 2012
Adipocyte;Apr-Jun2012, Vol. 1 Issue 2, p108
Academic Journal
Adenosine A1 receptor-deficient mice develop a phenotype of insulin resistance and grow fat. Participating pathophysiological pathways are not understood in detail yet, as discussed in our recent manuscript. This commentary further explores possible pathophysiological mechanisms with emphasis on the roles of the adipokines resistin, retinolbinding protein 4, adiponectin and the function of the gastric hormone ghrelin in adenosine mediated central regulation of energy balance. The postulate of an important function of ghrelin/A1AR axis provides a good hypothetical basis for further investigations to clarify the mechanism of A1AR-dependent metabolic homeostasis.


Related Articles

  • Serum Visfatin Levels, Adiposity and Glucose Metabolism in Obese Adolescents. Taşkesen, Derya; Kirel, Birgül; Us, Tercan // Journal of Clinical Research in Pediatric Endocrinology;Jun2012, Vol. 4 Issue 2, p76 

    Objective: Visfatin, an adipokine, has insulin-mimetic effects. The main determinants of both the production and the physiologic role of visfatin are still unclear. The aim of this study is to determine the relation of serum visfatin to adiposity and glucose metabolism. Methods: 40 pubertal...

  • Vaspin inhibits kallikrein 7 by serpin mechanism. Heiker, John; Klöting, Nora; Kovacs, Peter; Kuettner, E.; Sträter, Norbert; Schultz, Stephan; Kern, Matthias; Stumvoll, Michael; Blüher, Matthias; Beck-Sickinger, Annette // Cellular & Molecular Life Sciences;Jul2013, Vol. 70 Issue 14, p2569 

    The molecular target of the adipokine vaspin (visceral adipose tissue-derived serpin; serpinA12) and its mode of action are unknown. Here, we provide the vaspin crystal structure and identify human kallikrein 7 (hK7) as a first protease target of vaspin inhibited by classical serpin mechanism...

  • 37. A Novel Form of Enzyme Replacement Therapy for ADA-Deficiency: In Vivo Transduction by Neonatal Injection of Lentivirus Expressing ADA Carbonaro, Denise A.; Jin, Xiangyang; Petersen, Denise; Kohn, Donald B. // Molecular Therapy;Jun2005, Vol. 11, p15 

    An abstract of the article "A Novel Form of Enzyme Replacement Therapy for ADA-Deficiency: In Vivo Transduction by Neonatal Injection of Lentivirus Expressing ADA," by Denise A. Carbonaro, Xiangyang Jin, Denise Petersen and Donald B. Kohn is presented.

  • Long-term exposure to nonylphenol affects insulin signaling in the liver of adult male rats. Jubendradass, R; D’Cruz, SC; Mathur, PP // Human & Experimental Toxicology;Sep2012, Vol. 31 Issue 9, p868 

    In the present study, we sought to investigate the long-term effects of nonylphenol (NP) on insulin signaling and glucose metabolism in liver. Furthermore, reactive oxygen species (ROS) in liver was evaluated as it is known to induce insulin resistance. Rats were administered NP by oral gavage...

  • Fatal Congenital Hypertrophic Cardiomyopathy and a Pancreatic Nodule Morphologically Identical to Focal Lesion of Congenital Hyperinsulinism in an Infant with Costello Syndrome: Case Report and Review of the Literature. SHEFFIELD, BRANDON S.; YIP, STEPHEN; RUCHELLI, EDUARDO D.; DUNHAM, CHRISTOPHER P.; SHERWIN, ELIZABETH; BROOKS, PAUL A.; SUR, AMITAVA; SINGH, AVASH; HUMAN, DEREK G.; PATEL, MILLAN S.; LEE, ANNA F. // Pediatric & Developmental Pathology;May/Jun2015, Vol. 18 Issue 3, p237 

    Costello syndrome is characterized by constitutional mutations in the proto-oncogene HRAS, causing dysmorphic features, multiple cardiac problems, intellectual disability, and an increased risk of neoplasia. We report a male infant with dysmorphic features, born prematurely at 32 weeks, who,...

  • Stress Hyperglycemia, Insulin Treatment, and Innate Immune Cells. Fangming Xiu; Stanojcic, Mile; Li Diao; Jeschke, Marc G. // International Journal of Endocrinology;2014, p1 

    Hyperglycemia (HG) and insulin resistance are the hallmarks of a profoundly altered metabolism in critical illness resulting from the release of cortisol, catecholamines, and cytokines, as well as glucagon and growth hormone. Recent studies have proposed a fundamental role of the immune system...

  • Predictors and prevention of diabetic cardiomyopathy. Chavali, Vishalakshi; Tyagi, Suresh C.; Mishra, Paras K. // Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy;2013, Vol. 6, p151 

    Despite our cognizance that diabetes can enhance the chances of heart failure, causes multiorgan failure,and contributes to morbidity and mortality, it is rapidly increasing menace worldwide. Less attention has been paid to alert prediabetics through determining the comprehensive predictors of...

  • Inflammatory syndrome ADA2 deficiency. Vogan, Kyle // Nature Genetics;Apr2014, Vol. 46 Issue 4, p325 

    The article present the study published in the "New England Journal of Medicine" in a 2014 issue by researcher Ivona Aksentijevich and medical geneticist Ephart Levy Lahad for mutations in CERC1 gene which encodes for adenosine deaminase 2 (ADA2) that causes adenosine inflammatory deficiency.

  • Extreme Thrombocytosis in Response to PEG-ADA: Early Therapeutic and Risk Indicator. Marwaha, Vijay Rai; Italia, Dinaz Homi; Esper, Frank; Hostoffer, Robert W. // Clinical Pediatrics;Mar2000, Vol. 39 Issue 3, p183 

    Focuses on adenosine deaminase (ADA) deficiency as an autosomal recessive form of severe combined immunodeficiency disease (SCID). Frequency of SCID in the United States; Development of therapeutic options for ADA-deficient patients; Conclusion.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics